Call us at (440) 366-4310


Red5 Pharmaceuticals LLC is developing novel diagnostic assays that prospectively determine whether a patient will respond to chemotherapy. Its technology enables a personalized medicine approach to chemotherapy— the customization of patient healthcare by tailoring specific treatment decisions and practices to an individual.

The company received a $25,000 Innovation Fund award in May 2014.